Vins Bioproducts Limited - pharma in Maheswaram, Telangana, India. FY 2026 financials and compliance.
CIN U24110TG1997PLC026437 Incorporated 17 February 1997 ROC Hyderabad HQ Maheswaram, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹210.48 Cr
▲ 34.00% YoY
EBITDA · FY 2025
*****
▲ 38.00% YoY
Net profit · FY 2025
*****
▲ 38.00% YoY
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹20 Cr
Issued & subscribed
Open charges
₹25.66 Cr
Satisfied ₹5.46 Cr
Company age
29 yrs
Est. 1997
Last financials
Mar 2025
Balance sheet date

About Vins Bioproducts Limited

Data last updated: 16 February 2026

Vins Bioproducts Limited is a public limited company based in Maheswaram, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 February 1997, the company has been in operation for over 29 years.

Registered with ROC Hyderabad under CIN U24110AP1997PTC026437.

Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹20 Cr. Formerly known as Vins Bioproducts Private Limited. It is led by directors including Balkishan Badruka and Shreedas Narayandas Daga.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Maheswaram, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹210.48 Cr, a growth of 34% compared to the previous year.

The company is associated with 1 brand - Vins Bio Products. As per MCA filings, the company has open charges of ₹25.66 Cr and satisfied charges of ₹5.46 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vinsbio.in.

Company Details of Vins Bioproducts Limited
CIN U24110TG1997PLC026437
Registration Number 026437
Incorporation Date 17 February 1997
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Sy. No. 117 Thimmapur Village, Kothur Mandal, Maheswaram, Telangana, India – 509325
  • Industry
    Pharma, Drug Formulation & Development
Company report
Vins Bioproducts Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Vins Bioproducts Limited report

Financials, compliance, directors, charges, ownership and filings for Vins Bioproducts Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Vins Bioproducts Limited

Vins Bioproducts Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24110TG1997PLC026437, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24110TG1997PLC026437 Current
U24110AP1997PTC026437 Previous
U24110AP1997PLC026437 Previous

Associated Brands with Vins Bioproducts Limited

Vins Bioproducts Limited operates one associated brand: Vins Bio Products. These brands represent Vins Bioproducts Limited's diversified market presence and brand portfolio.

Brand Description Website
Antisera and antitoxins for snake bites and infections are developed. vinsbio.in

Competitors & Alternatives of Vins Bioproducts Limited

Brands and companies operating in the same space as Vins Bioproducts Limited include Vaxcyte, Serum Institute of India, Biological E and 7 more.

Competitor Description Location Founded
Vaxcyte Vaxcyte Vaccines for infectious diseases are developed using cell-free protein synthesis. Foster City, United States, United States 2013
Serum Institute of India Serum Institute of India Vaccines and immuno-biological drugs for infectious diseases are manufactured. Pune, India, India 1966
Biological E Biological E Vaccines and therapeutics for multiple diseases are developed and marketed. Hyderabad, India, India 1953
RedHill Biopharma RedHill Biopharma Developer of therapeutics for the treatment of gastrointestinal and infectious diseases Ramat Gan, Israel, Israel 2009
Valneva Valneva Prophylactic vaccines for infectious diseases are developed and advanced. Lyon, France, France 1999
Freeline Freeline Gene therapy platform is developed for chronic disease treatments. Stevenage, United Kingdom, United Kingdom 2015
Vir Biotechnology Vir Biotechnology Developer of therapeutics for the treatment of infectious diseases San Francisco, United States, United States 2017
Cidara Therapeutics Cidara Therapeutics Novel anti-infectives for bacterial and fungal infections are developed. San Diego, United States, United States 2013
Osivax Osivax Vaccines against mutating pathogens are developed using nanoparticle technology. Lyon, France, France 2017
StrideBio StrideBio AAV-based gene therapies for rare diseases are developed. Durham, United States, United States 2015

Business Activity of Vins Bioproducts Limited

Vins Bioproducts Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Board of Directors of Vins Bioproducts Limited

Vins Bioproducts Limited is currently managed by 8 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Balkishan Badruka Director 30 Aug 2017 8 Years 10 Months Current
Shreedas Narayandas Daga Whole-Time Director 01 Aug 2011 14 Years 11 Months Current
Sunaina Bihani Director 18 Jun 2021 5 Years 0 Months Current
Varun Jain Director 13 Jun 2024 2 Years 0 Months Current
Siddarth Daga Managing Director 01 Apr 2013 13 Years 3 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Vins Bioproducts Limited FY 2025 filings available

Vins Bioproducts Limited reported revenue of ₹210.48 Cr (up 34% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹210.48 Cr ▲ 34%
Profit
***** ▲ 38%
EBITDA
***** ▲ 38%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Vins Bioproducts Limited

Open charges
₹25.66 Cr
Satisfied charges
₹5.46 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹15.21 Cr
Canara Bank₹10.00 Cr
Citi Bank N.A.₹0.32 Cr
Others₹0.12 Cr
Latest charge details
DateLenderAmountStatus
06 May 2024 Others ₹12.13 Lakh Open
06 Jan 2021 Hdfc Bank Limited ₹1.21 Cr Open
17 Jul 2018 Hdfc Bank Limited ₹14 Cr Open
09 Jun 2014 Citi Bank N.A. ₹32.45 Lakh Open
18 Aug 2004 Canara Bank ₹10 Cr Open

Total charge records: 12 View all charges

Employees and EPFO Compliance at Vins Bioproducts Limited

View historical data on people associated with Vins Bioproducts Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Vins Bioproducts Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Vins Bioproducts Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Vins Bioproducts Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Vins Bioproducts Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Vins Bioproducts Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Vins Bioproducts Limited

MSME Payment Delays by Vins Bioproducts Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Vins Bioproducts Limited

Subsidiaries & Group Companies of Vins Bioproducts Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vins Bioproducts Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Vins Bioproducts Limited

MCA Filings & Documents of Vins Bioproducts Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Vins Bioproducts Limited

Activity
30 Sep 2025
Vins Bioproducts Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
20 May 2025
A charge with Hdfc Bank Limited of Rs. 14.00 Cr registered on 17 Jul 2018 with Charge ID 100198954 was modified on 20 May 2025.
Activity
31 Mar 2025
Vins Bioproducts Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
16 Jan 2025
Siddarth Daga was appointed as a Ceo on 16 Jan 2025 & has been associated with this company since 1 year 5 months.
Charges
05 Dec 2024
A charge registered on 06 Sep 2021 via Charge ID 100512289 with Others was fully satisfied on 05 Dec 2024.
Directors
13 Jun 2024
Varun Jain was appointed as a Director on 13 Jun 2024 & has been associated with this company since 2 years 26 days.

Frequently Asked Questions about Vins Bioproducts Limited

Vins Bioproducts Limited is an active public limited company in the pharma sector based in Maheswaram, Telangana, India. It was incorporated on 17 February 1997 (29+ years old) and is registered under CIN U24110TG1997PLC026437.

Vins Bioproducts Limited reported revenue of ₹210.48 Cr for FY 2025 (up 34.00% YoY).

The current directors of Vins Bioproducts Limited are:

The primary industry of Vins Bioproducts Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Vins Bioproducts Limited can be reached at the registered office: Sy. No. 117 Thimmapur Village, Kothur Mandal, Maheswaram, Telangana, India – 509325, or through the website vinsbio.in.

The authorised capital is ₹20 Cr, and the paid-up capital is ₹20 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available